BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parasido E, Avetian GS, Naeem A, Graham G, Pishvaian M, Glasgow E, Mudambi S, Lee Y, Ihemelandu C, Choudhry M, Peran I, Banerjee PP, Avantaggiati ML, Bryant K, Baldelli E, Pierobon M, Liotta L, Petricoin E, Fricke ST, Sebastian A, Cozzitorto J, Loots GG, Kumar D, Byers S, Londin E, DiFeo A, Narla G, Winter J, Brody JR, Rodriguez O, Albanese C. The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells. Mol Cancer Res 2019;17:1815-27. [PMID: 31164413 DOI: 10.1158/1541-7786.MCR-19-0191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Lyubetskaya A, Rabe B, Fisher A, Lewin A, Neuhaus I, Brett C, Brett T, Pereira E, Golhar R, Kebede S, Font-tello A, Mosure K, Van Wittenberghe N, Mavrakis KJ, Macisaac K, Chen BJ, Drokhlyansky E. Assessment of spatial transcriptomics for oncology discovery. Cell Reports Methods 2022. [DOI: 10.1016/j.crmeth.2022.100340] [Reference Citation Analysis]
2 Bhardwaj V, He J, Jain A. Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity. Med Oncol 2022;39:227. [PMID: 36175776 DOI: 10.1007/s12032-022-01834-5] [Reference Citation Analysis]
3 Gautam SK, Basu S, Aithal A, Dwivedi NV, Gulati M, Jain M. Regulation of pancreatic cancer therapy resistance by chemokines. Semin Cancer Biol 2022:S1044-579X(22)00196-1. [PMID: 36064086 DOI: 10.1016/j.semcancer.2022.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Li X, Li M. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents. Med Res Rev 2022. [PMID: 36029178 DOI: 10.1002/med.21924] [Reference Citation Analysis]
5 Li F, Mao C, Yeh S, Xin J, Wang P, Shi Q, Ming X. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer. Int J Pharm 2022;625:122076. [PMID: 35931394 DOI: 10.1016/j.ijpharm.2022.122076] [Reference Citation Analysis]
6 Naeem A, Gupta N, Naeem U, Khan MJ, Elrayess MA, Cui W, Albanese C. A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells. Cell Cycle 2022;:1-14. [PMID: 35412950 DOI: 10.1080/15384101.2022.2060641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Naeem A, Gupta N, Arzoo N, Naeem U, Khan MJ, Choudhry MU, Cui W, Albanese C. A Survey and Critical Evaluation of Isolation, Culture, and Cryopreservation Methods of Human Amniotic Epithelial Cells. Cell Cycle 2022;:1-19. [PMID: 35289707 DOI: 10.1080/15384101.2021.2020015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Issa NT, Wathieu H, Glasgow E, Peran I, Parasido E, Li T, Simbulan-rosenthal CM, Rosenthal D, Medvedev AV, Makarov SS, Albanese C, Byers SW, Dakshanamurthy S. A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer. Ecotoxicology and Environmental Safety 2022;233:113330. [DOI: 10.1016/j.ecoenv.2022.113330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pang K, Lee J, Kim J, Park J, Park Y, Hong E, An H, Ooshima A, Son M, Park KS, Cho JH, Lee C, Song YS, Yang KM, Kim SJ. Degradation of DRAK1 by CUL3/SPOP E3 Ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells. Cell Death Dis 2022;13:169. [PMID: 35194034 DOI: 10.1038/s41419-022-04619-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Massó-vallés D, Beaulieu M, Jauset T, Giuntini F, Zacarías-fluck MF, Foradada L, Martínez-martín S, Serrano E, Martín-fernández G, Casacuberta-serra S, Castillo Cano V, Kaur J, López-estévez S, Morcillo MÁ, Alzrigat M, Mahmoud L, Luque-garcía A, Escorihuela M, Guzman M, Arribas J, Serra V, Larsson L, Whitfield JR, Soucek L. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding. Cancer Research Communications 2022;2:110-130. [DOI: 10.1158/2767-9764.crc-21-0103] [Reference Citation Analysis]
11 Ala M. Target c-Myc to treat pancreatic cancer. Cancer Biol Ther 2022;:1-17. [PMID: 34978469 DOI: 10.1080/15384047.2021.2017223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
12 Alkhilaiwi F. Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy. Front Oncol 2021;11:761986. [PMID: 34737964 DOI: 10.3389/fonc.2021.761986] [Reference Citation Analysis]
13 Schneider G, Wirth M, Keller U, Saur D. Rationale for MYC imaging and targeting in pancreatic cancer. EJNMMI Res 2021;11:104. [PMID: 34637026 DOI: 10.1186/s13550-021-00843-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hasle N, Cooke A, Srivatsan S, Huang H, Stephany JJ, Krieger Z, Jackson D, Tang W, Pendyala S, Monnat RJ Jr, Trapnell C, Hatch EM, Fowler DM. High-throughput, microscope-based sorting to dissect cellular heterogeneity. Mol Syst Biol 2020;16:e9442. [PMID: 32500953 DOI: 10.15252/msb.20209442] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
15 Tang D, Huang T, Tian Q, Wang J. MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells. Drug Des Devel Ther 2021;15:1749-63. [PMID: 33953544 DOI: 10.2147/DDDT.S288841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bhattarai RS, Kumar V, Romanova S, Bariwal J, Chen H, Deng S, Bhatt VR, Bronich T, Li W, Mahato RI. Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer. J Control Release 2021;329:585-97. [PMID: 33010334 DOI: 10.1016/j.jconrel.2020.09.052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lankes K, Hassan Z, Doffo MJ, Schneeweis C, Lier S, Öllinger R, Rad R, Krämer OH, Keller U, Saur D, Reichert M, Schneider G, Wirth M. Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC. Mol Oncol 2020;14:3048-64. [PMID: 33099868 DOI: 10.1002/1878-0261.12835] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
18 Naeem A, Dakshanamurthy S, Walthieu H, Parasido E, Avantaggiati M, Tricoli L, Kumar D, Lee RJ, Feldman A, Noon MS, Byers S, Rodriguez O, Albanese C. Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells. Prostate 2020;80:1233-43. [PMID: 32761925 DOI: 10.1002/pros.24050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zhong M, Fu L. Culture and application of conditionally reprogrammed primary tumor cells. Gastroenterol Rep (Oxf) 2020;8:224-33. [PMID: 32665854 DOI: 10.1093/gastro/goaa023] [Reference Citation Analysis]
20 Lankes K, Hassan Z, Doffo M, Schneeweis C, Lier S, Öllinger R, Rad R, Krämer O, Keller U, Saur D, Reichert M, Schneider G, Wirth M. Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC.. [DOI: 10.1101/2020.07.01.182162] [Reference Citation Analysis]
21 Ambrosini G, Dalla Pozza E, Fanelli G, Di Carlo C, Vettori A, Cannino G, Cavallini C, Carmona-Carmona CA, Brandi J, Rinalducci S, Scupoli MT, Rasola A, Cecconi D, Palmieri M, Dando I. Progressively De-Differentiated Pancreatic Cancer Cells Shift from Glycolysis to Oxidative Metabolism and Gain a Quiescent Stem State. Cells 2020;9:E1572. [PMID: 32605166 DOI: 10.3390/cells9071572] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
22 Liu W, Ju L, Cheng S, Wang G, Qian K, Liu X, Xiao Y, Wang X. Conditional reprogramming: Modeling urological cancer and translation to clinics. Clin Transl Med 2020;10:e95. [PMID: 32508060 DOI: 10.1002/ctm2.95] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Hasle N, Cooke A, Srivatsan S, Huang H, Stephany JJ, Krieger Z, Jackson D, Tang W, Pendyala S, Monnat RJ, Trapnell C, Hatch EM, Fowler DM. Visual Cell Sorting: A High-throughput, Microscope-based Method to Dissect Cellular Heterogeneity.. [DOI: 10.1101/856476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]